期刊
BIOMARKERS IN MEDICINE
卷 8, 期 5, 页码 653-661出版社
FUTURE MEDICINE LTD
DOI: 10.2217/BMM.14.9
关键词
extracellular vesicles; microparticles; multiple sclerosis; secondary progressive; treatment
资金
- Basque Government: SAIOTEK program [SAIO11-PC11BN3]
- Health Department [GV-2011111028]
Aim: To evaluate whether circulating microparticles (MPs) derived from three cell subtypes (platelets, total leukocytes or monocytes) obtained from multiple sclerosis (MS) patients were modulated depending on the clinical status and to investigate the effect of treatments on MP levels. Patients & methods: The MP counts were assessed with flow cytometry. Results: The platelet-derived MP level was higher in untreated MS patients than controls. Relapsing-remitting patients showed the highest levels in the three subtypes of MP while secondary progressive patients presented similar levels to those of healthy controls. Treatments had significant effects increasing the three subtypes of MP counts. Conclusion: We suggest that MPs play a role in MS pathogenesis, reflecting disease status with an increment of their shedding during inflammatory periods and turning to baseline during chronic progressive degeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据